Walgreens Boots Alliance(US:WBA) ZACKS·2025-06-26 14:06Core Insights - Walgreens Boots Alliance, Inc. (WBA) reported adjusted earnings per share (EPS) of 38 cents for Q3 fiscal 2025, a decline of 39.7% year-over-year, but exceeded the Zacks Consensus Estimate by 11.76% [1] - Total sales for Q3 reached $38.99 billion, reflecting a year-over-year increase of 7.2% and surpassing the Zacks Consensus Estimate by 6.5% [2][9] - The company has withdrawn its fiscal 2025 guidance due to a pending acquisition deal with Sycamore Partners, expected to close in late 2025 [12][13] Financial Performance - The gross profit for Q3 was $6.51 billion, up 0.75% year-over-year, despite an 8.7% increase in the cost of sales, leading to a gross margin contraction of 108 basis points to 16.7% [8][9] - Selling, general and administrative (SG&A) expenses rose 1.6% year-over-year to $6.49 billion, with an adjusted operating profit of $13 million compared to $66 million in the previous year [10] Segment Performance - U.S. Retail Pharmacy segment sales increased by 7.8% year-over-year to $30.7 billion, with comparable sales up 10.3% [4] - International revenues grew by 7.8% year-over-year to $6.2 billion, with notable increases in Germany and Boots UK [6] - U.S. Healthcare reported revenues of $2.1 billion, with mixed performance across its sub-segments [7] Market Reaction - Following the earnings announcement, Walgreens shares rose by 0.9% in pre-market trading [2]